T J Boggon Selected Research

docosahexaenoylascorbic acid (DHA-As)

12/2017

Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T J Boggon Research Topics

Disease

1	Hemolysis 12/2017
1	Leukemia 12/2017
1	Neoplasms (Cancer) 12/2017
1	Hemolytic Anemia 12/2017
1	Neoplasm Metastasis (Metastasis) 01/2009
1	Lung Neoplasms (Lung Cancer) 01/2009
1	Obesity 06/2001

Drug/Important Bio-Agent (IBA)

1	artenimol (dihydroartemisinin)IBA 12/2017
1	docosahexaenoylascorbic acid (DHA-As)IBA 12/2017
1	physcioneIBA 12/2017
1	EnzymesIBA 12/2017
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 12/2017
1	Phosphogluconate Dehydrogenase (Dehydrogenase, Phosphogluconate)IBA 12/2017
1	AMP-Activated Protein KinasesIBA 12/2017
1	Antimalarials (Antimalarial Agents)IBA 12/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2009
1	ErbB Receptors (EGF Receptor)IBA 01/2009
1	Gefitinib (Iressa)FDA Link 01/2009
1	Proteins (Proteins, Gene)FDA Link 06/2001

Therapy/Procedure

2	Therapeutics 12/2017 - 01/2009